ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,474,612 | +29.3% | 999,249 | +25.4% | 0.03% | +34.8% |
| Q2 2023 | $15,834,900 | +47.1% | 796,925 | +26.8% | 0.02% | +35.3% |
| Q1 2023 | $10,766,445 | +147.8% | 628,514 | +183.1% | 0.02% | +112.5% |
| Q4 2022 | $4,344,540 | -48.0% | 222,000 | +17.6% | 0.01% | -38.5% |
| Q2 2021 | $8,357,000 | -0.2% | 188,698 | 0.0% | 0.01% | -7.1% |
| Q1 2021 | $8,373,000 | -54.0% | 188,698 | -43.2% | 0.01% | -56.2% |
| Q4 2020 | $18,215,000 | +202.2% | 332,143 | +26.0% | 0.03% | +166.7% |
| Q3 2020 | $6,027,000 | -32.0% | 263,642 | -37.8% | 0.01% | -36.8% |
| Q2 2020 | $8,867,000 | +85.3% | 423,637 | +23.5% | 0.02% | +46.2% |
| Q1 2020 | $4,785,000 | +1.9% | 343,000 | +66.2% | 0.01% | +30.0% |
| Q4 2019 | $4,698,000 | – | 206,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |